RD-Biotech

RD-Biotech est membre de Lyonbiopôle

General information

3 rue Henri Baigue

25000 Besancon

Incorporated in: 2002/07/09

Number of employees: 25

Turnover: €2900K (in 2016)


More information

 

Main activity

Biomanufacturing platform: Plasmids, monoclonal antibodies up to several grams (murine, rat, human, guinea pig ...), recombinant proteins and antibodies (humanised and chimeric), cell lines. R&D or High quality grade New: Two new platforms: 1- Recombinant antibody engineering: mAb sequencing, Chimerization, Humanization, Phage Display Mouse and Llama (VHH) - 2 - Recombinant proteins cell free system and transfection platform (CHO-HEK cells ...) Development of biological tools, immunization and development of murine or rat clones, establishment of cell lines, vectors and cloning Analytical Services Ready-to-use FastELISA kits for the quantification of immunoglobulins (murine, human, rat, bovine), or protein A , or for isotyping mouse Ig Bioassay platform, characterization of the biological activity of antibodies, platform Octet. Rd-Biotech is a mAbexperts company (www.mabexperts.com)

Segmentation
Activities
Partnership opportunities / Licensing

Strategic area of application
In Vitro diagnostic


Application market
Dermatology & Cosmetology - Immune, AutoIm & Inflam. diseases - Infectiology - Parasitology


Activities
Therapeutics, Pharma or Biotech - CRO


Technologies
Cell Therapy - cell biology - Biobanking - Molecular Biology and Nucleic acid - Antibodies - Protein - Peptide